CClinicalTrials.gg
CompletedNCT04038697Updated May 4, 2026

Ischemic Conditioning Improves Walking Function Post Stroke

An interventional study of Ischemic Conditioning and Ischemic Conditioning Sham in Stroke, Stroke, Ischemic and Stroke Hemorrhagic, sponsored by Medical College of Wisconsin. Completed at 2 sites in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2018, registered Jul 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This innovative study will address scientific and clinical areas relatively unexplored in chronic stroke that could lead to greater recovery of walking. Ischemic Conditioning (IC) is a non-invasive, simple procedure that improves motor function, exercise performance and cardiovascular function in healthy controls, but it has never been applied to the stroke population. We postulate that IC enhances the recruitment of motoneurons and results in positive neural adaptations, improves vascular endothelial function and peripheral blood flow, and together these improvements result in an increased capacity to exercise and faster walking speed. Future studies will examine the effects of IC and traditional therapy at different time points of recovery post stroke, durability of IC, molecular mechanisms of neural and cardiovascular adaptation and the efficacy compared with other adjuncts.

Read the detailed description

This study will quantify the effects of Ischemic Conditioning and treadmill training on improvements in: walking speed, leg strength, neuromuscular fatigability and the hyperemic blood flow response to muscle contractions, and vascular endothelial function and aerobic exercise capacity. A randomized control design will be used with three groups of chronic stroke survivors enrolled for four weeks of training (3x/week; 12 sessions total). The groups are: IC + Treadmill Training, IC Sham + Treadmill Training, and IC only. We will also enroll a group of age- and sex-matched healthy control subjects who will undergo IC + Treadmill Training. All Aims will be tested concurrently over a five-year period. All studies will be performed in Cramer Hall at Marquette University in the Integrated Neural Engineering Rehabilitation Laboratories, the Human Performance Assessment Core, and the Physical Therapy Clinic.

Randomization of stroke patients to the three intervention groups will be performed by using randomized block designs (randomly chosen block sizes of 3, 6 and 9). This number accounts for possible dropouts and the use of non- parametric methods.

02

Conditions studied

  • Stroke
  • Stroke, Ischemic
  • Stroke Hemorrhagic
  • Stroke, Cardiovascular

Keywords

  • Stroke
  • Rehabilitation
  • Ischemic Conditioning
  • Treadmill Training
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 132 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Medical College of Wisconsin is the lead sponsor of 540 studies on the registry; 120 are open to participants now.

Of its 71 completed or terminated interventional studies of FDA-regulated products, 56 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (Stroke Survivors):

  1. be ≥ 1 year post diagnosis of a unilateral, cortical stroke and have residual lower extremity paresis
  2. be between the ages of 18-85
  3. be able to give informed consent
  4. walk slower than normative values based on age and sex

Exclusion Criteria (Stroke Survivors):

  1. history of deep vein thrombosis or any condition in which transient ischemia to the lower extremity is contraindicated
  2. inability to follow 2 step commands
  3. chronic low back or hip pain
  4. history of substance abuse
  5. history of head trauma
  6. comorbid neurological disorder
  7. any uncontrolled medical condition
  8. pacemaker
  9. any condition where fatiguing contractions or resisted leg contractions are contraindicated
  10. inability to walk for 5 minute bouts on a treadmill with a harness supporting up to 50% of the body weight at 80% of over-ground self-selected walking speed.

Inclusion Criteria (Healthy Control Subjects):

  1. be between ages of 18-85
  2. be able to give informed consent

Exclusion Criteria (Healthy Control Subjects):

  1. Those listed above for stroke survivors
  2. History of Stroke
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    Ischemic Conditioning + Treadmill Training

    Study participants with prior history of stroke will receive both ischemic conditioning and treadmill training.

    Procedure: Ischemic Conditioning · Procedure: Treadmill Training

  • Placebo comparator
    Ischemic Conditioning Sham + Treadmill Training

    Study participants with prior history of stroke will receive both ischemic conditioning sham and treadmill training.

    Procedure: Ischemic Conditioning Sham · Procedure: Treadmill Training

  • Active comparator
    Ischemic Conditioning Only

    Study participants with prior history of stroke will receive only ischemic conditioning.

    Procedure: Ischemic Conditioning

  • Active comparator
    Healthy Control - Ischemic Conditioning + Treadmill Training

    Healthy control participants will receive both ischemic conditioning and treadmill training.

    Procedure: Ischemic Conditioning · Procedure: Treadmill Training

Interventions

  • ProcedureIschemic Conditioning

    Ischemic conditioning is a well-defined, non-invasive procedure which consists of inflating a blood pressure cuff around a limb (in our study, the paretic leg), inflating the cuff to 225 mmHg to occlude blood flow to the limb for 5 minutes, releasing the cuff for 5 minutes, and repeating 5 times. In our study, participants assigned to the IC Only and IC + Treadmill Training groups will undergo twelve sessions of ischemic conditioning over a four-week period.

  • ProcedureIschemic Conditioning Sham

    Ischemic conditioning sham consists of the same setup as ischemic conditioning, which consists of inflating a blood pressure cuff around a limb (in our study, the paretic leg), inflating the cuff to 10 mmHg for 5 minutes, releasing the cuff for 5 minutes, and repeating 5 times. 10 mmHg is a sufficient inflation pressure for study participants to perceive some cuff tightness, but is not high enough to occlude blood flow. In our study, participants assigned to the IC Sham + Treadmill Training groups will undergo twelve sessions of ischemic conditioning sham over a four-week period.

  • ProcedureTreadmill Training

    Participants will perform 3 treadmill training sessions/week for a 4 week period (12 sessions total). Treadmill training will immediately follow IC or IC Sham. Personnel performing the treadmill training will be blinded to the IC treatment group. Subjects will walk on a treadmill for six, 5-minute intervals. Walking speed will be continuously adjusted to maintain heart rate between 50% and 60% of age-adjusted heart rate reserve to minimize the confounder of intensity. If individuals cannot walk at 80% of their overground self-selected walking speed, for 5 minutes, they will be assisted into a body weight support harness. Body weight support will be adjusted (up to 50%) such that individuals can walk at 80% of their over ground walking speed for five minutes and adjusted accordingly throughout the session. Participants assigned to the Treadmill + IC and Treadmill + IC Sham groups will receive Treadmill Training.

06

What researchers measure

Primary outcomes

  1. Self Selected Walking Speed

    We will measure how fast participants walk during the 10 meter walk test.

    Time frame: Change from baseline to 4 weeks.

Secondary outcomes

  1. Knee Extensor Leg Strength

    Pre-treatment and after 1, 6, and 12 sessions of ischemic conditioning. We will also test 1 month post intervention

    Time frame: Change from baseline to 4 weeks.

  2. Knee Extensor Fatigability

    Pre-treatment and after 1, 6, and 12 sessions of ischemic conditioning. We will also test 1 month post intervention

    Time frame: Change from baseline to 4 weeks.

  3. Flow Mediated Dilation of Non-Paretic Brachial Artery and Paretic Popliteal Artery

    Pre-treatment and after 1, 6, and 12 sessions of ischemic conditioning. We will also test 1 month post intervention

    Time frame: Change from baseline to 4 weeks.

  4. Peak Oxygen Consumption

    Using a recumbent bicycle and metabolic cart, we will test whole body oxygen consumption during a graded exercise test

    Time frame: Change from baseline to 4 weeks.

Other outcomes

  1. Six minute walk test

    Clinical test for walking endurance

    Time frame: Change from baseline to 4 weeks.

  2. Lower Extremity Fugl Meyer

    Clinical test for coordination

    Time frame: Change from baseline to 4 weeks.

  3. Manual Muscle Test

    Clinical test for strength

    Time frame: Change from baseline to 4 weeks.

  4. Modified Ashworth Scale

    Clinical test for spasticity. The Modified Ashworth scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Higher scores indicate worse spasticity. The scores and scale are as follows: 0: No increase in muscle tone 1. Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of motion. 2. More marked increase in muscle tone through most of the range of motion, but affected part(s) easily moved 3. Considerable increase in muscle tone, passive movement difficult 4. Affected part(s) rigid in flexion or extension

    Time frame: Change from baseline to 4 weeks.

  5. Bipolar Surface Electromyography (EMG) Measurements

    Bipolar surface EMG of bilateral lower extremities will be measured during walking using electrodes placed on the following muscles: rectus femoris, vastus medialis, medial hamstrings, tibialis anterior, and medial gastrocnemius.

    Time frame: Change from baseline to 4 weeks.

  6. Voluntary Activation of Paretic Muscle

    Voluntary activation (neural drive to the muscle) will be assessed by stimulating the motor nerve with a brief stimulus (superimposed twitch) while the subject performs a maximal voluntary contraction (MVC).

    Time frame: Change from baseline to 4 weeks.

  7. Surface EMG Motor Unit Measurements

    Surface motor unit potentials will be recorded from the vastus lateralis (VL) muscle during muscle contractions using a multi-channel linear array of 64 EMG electrodes

    Time frame: Change from baseline to 4 weeks.

  8. Hyperemic Blood Flow in Response to Muscle Contractions

    Blood flow through the superficial femoral artery will be measured before and immediately after knee extensor muscle contractions using Doppler ultrasound.

    Time frame: Change from baseline to 4 weeks.

  9. Heart Rate Variability (HRV)

    We will use HRV analysis to determine the effects of IC and treadmill training on sympathetic and parasympathetic control of heart rate at the same time points as above.

    Time frame: Change from baseline to 4 weeks.

  10. Step Cadence

    The number of steps per minute when walking at self-selected walking speed will be measured.

    Time frame: Change from baseline to 4 weeks.

  11. Step Length

    The average step length during self-selected walking speed will be measured.

    Time frame: Change from baseline to 4 weeks.

  12. Step Velocity

    Step velocity, the product of cadence and step length, expressed in units of distance per time, will be measured during self-selected walking speed.

    Time frame: Change from baseline to 4 weeks.

  13. Ground Reaction Force

    Ground reaction force (N) will be measured during the different phases of gait during the 10 meter walk test and reported separately.

    Time frame: Change from baseline to 4 weeks.

  14. Ankle, Hip and Knee Joint Trajectories

    Ankle, hip and knee joint trajectories (Angle) will be measured separately, in both legs, during the different phases of gait during the 10 meter walk test and reported as separate values.

    Time frame: Change from baseline to 4 weeks.

07

Study locations

2 sites
  • Medical College of Wisconsin
    Milwaukee, Wisconsin 53226, United States
  • Marquette University
    Milwaukee, Wisconsin 53233, United States
08

References and documents

Study documents

  • Study protocol · Jul 26, 2019
  • Statistical analysis plan · Jul 26, 2019
  • Informed consent form · Jul 26, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04038697
Lead sponsor
Medical College of Wisconsin
Collaborators
Marquette University
Responsible party
Matthew J. Durand (Assistant Professor, Medical College of Wisconsin) — Principal investigator
First posted
Jul 31, 2019
Start date
Dec 20, 2018
Primary completion
Dec 16, 2025
Completion
Jan 9, 2026
Last update
May 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion